MeAgain Launches the MeAgain Index, Establishing the First Comprehensive Quarterly Benchmark for the GLP-1 Ecosystem

The index combines real-world behavioral data from hundreds of thousands of members on the MeAgain platform alongside external market signals to rank the top GLP-1 brands and products

NEW YORK--(BUSINESS WIRE)--MeAgain, a leading GLP-1 lifestyle companion app, today announced the launch of the MeAgain Index, a quarterly report and ranking of the top GLP-1 brands, trending GLP-1 products and leading GLP-1 medications. This recurring report is the first of its kind to track consumer demand, market movements and cultural shifts across the GLP-1 landscape.

GLP-1 medications are reshaping healthcare and also consumer behavior more widely, yet there is no standard source for tracking what is happening across the category. Existing information relies on fragmented datasets, many of which are hard for the public to access. The MeAgain Index addresses that gap with a standardized evaluation of the GLP-1 ecosystem, showing what is gaining or losing momentum quarter over quarter.

“MeAgain has grown to a size where we have a uniquely informed view of the GLP-1 market,” said Martyn Strydom, Co-Founder & CEO of MeAgain. “The MeAgain Index is built to be the go-to authority and benchmark that consumers, brands and journalists can turn to when they want to understand trends and changes in the GLP-1 landscape.”

Rankings Built on Access, Use, and Impact

Each quarter, the MeAgain Index delivers comprehensive rankings across three categories – Top GLP-1 Brands, Trending GLP-1 Products, and Leading GLP-1 Medications – using a proprietary methodology built around three dimensions:

• Access: Whether products are easy to find, understand and acquire
• Use: Real-world consumer interest, adoption and adherence
• Impact: Health outcomes, quality of life improvements and consumer sentiment

The MeAgain Index is built on top of engagement data from hundreds of thousands users, and millions of tracked products on the MeAgain platform. By combining this proprietary data with select signals across the wider GLP-1 ecosystem, including product launches, brand and retailer partnerships, clinical trial data, new research, social media trends, demand & visibility in AI channels and third-party reported data, the MeAgain Index provides the most comprehensive report and category rankings available of real-world GLP-1 consumer trends.

The MeAgain Index will continue to evolve with new data sources as the platform grows and GLP-1 treatment continues to change. The MeAgain Index is available today at meagain.com/index, where readers can access the complete rankings, review the full methodology, and register to receive future quarterly editions.

About MeAgain

MeAgain is a lifestyle support app designed to simplify the complexities of using GLP-1 medications. Available on iOS and Android, the app provides personalized tools for nutrition tracking, side effect management and healthy habit building. For more information, visit www.meagain.com.